Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1) by Alessandro D. Santin, Stefania Bellone, Natalia Buza, Peter E. Schwartz

Connect to this object online.

Utility of next generation sequencing to unequivocally establish clonality in synchronous vs metastatic endometrial and ovarian carcinomas by Michelle Greenman, Stefania Bellone, Tobias Hartwich, Natalia Buza, Alessandro D. Santin

Connect to this object online.

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma by Silvia Pelligra, Natalia Buza, Pei Hui, Stefania Bellone, Burak Zeybek, Elena Ratner, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin

Connect to this object online.

Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites by Jessie Y. Li, Levent Mutlu, Joan Tymon-Rosario, Wafa Khadraoui, Nupur Nagarkatti, Pei Hui, Natalia Buza, Lingeng Lu, Peter Schwartz, Gulden Menderes

Connect to this object online.

Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer by Benjamin B. Albright, Jonathan D. Black, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Natalia Buza, Pei Hui, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena S. Ratner, Babak Litkouhi, Peter E. Schwartz

Connect to this object online.